Company: CERO
Filing Date: 2025-10-14
Form Type: 8-K
Source: 0001213900-25-098421
Chunk: 0

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-10-14
Form: 8-K
Item: Item 3.02
Chunk 0
---
Item 3.02 Unregistered Sales of Equity Securities.

The information provided in Item 1.01 with respect
to the issuance of the shares of Series E Preferred Stock pursuant to the Securities Purchase Agreement is incorporated herein by reference.
All such securities will not be registered under the Securities Act in reliance on the exemption from registration provided by Section
4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder, or under any state securities laws. The Company
relied on this exemption from registration in entering into the Securities Purchase Agreement and the Company will rely upon this exemption
from registration in issuing such securities based in part on representations made by the PIPE Investors. The securities may not be offered
or sold in the United States absent registration or an applicable exemption from registration requirements. Neither this Current Report
on Form 8-K, nor the exhibits attached hereto, is an offer to sell or the solicitation of an offer to buy the securities described herein.

Item 9.01 Financial Statements and Exhibits.